Keyphrases
In Vivo Effects
100%
Antiphospholipid Antibodies
100%
Antiphospholipid Syndrome
100%
Coversin
100%
Complement C5 Inhibitor
100%
Tissue Factor Expression
60%
Thrombus
60%
Antibody-mediated
60%
Phosphate Buffer
60%
Thrombosis
40%
Normal Human Serum
40%
High Titer
20%
Recombinant Protein
20%
Tissue Factor
20%
Complement Activation
20%
Treatment Group
20%
Anticardiolipin
20%
C57BL
20%
Thrombogenesis
20%
Anticardiolipin Antibodies
20%
Massive Thrombus
20%
Proteinase Inhibitor
20%
Complement Cascade
20%
Complement Inhibition
20%
First Injection
20%
Complement Component 5
20%
Buffer Control
20%
Medicine and Dentistry
Antiphospholipid Antibody
100%
Complement Component C5 Inhibitor
100%
Nomacopan
100%
Antiphospholipid Syndrome
83%
Thromboplastin
66%
Thrombus
66%
Buffer
50%
Thrombosis
33%
Upregulation
16%
Blood Clotting
16%
Cardiolipin Antibody
16%
Complement Activation
16%
Protein Inhibitor
16%
Recombinant Protein
16%
Complement Component C5
16%
Complement Inhibition
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antiphospholipid Antibody
100%
Complement Component C5 Inhibitor
100%
Nomacopan
100%
Antiphospholipid Syndrome
83%
Thromboplastin
66%
Thrombus
66%
Buffer
50%
Normal Human
33%
Thrombosis
33%
Recombinant Protein
16%
C57BL 6 Mouse
16%
Cardiolipin Antibody
16%
Protein Inhibitor
16%
Complement Component C5
16%
Immunology and Microbiology
Phospholipid Antibody
100%
Nomacopan
100%
Complement Component C5 Inhibitor
100%
Antiphospholipid Syndrome
83%
Thromboplastin
66%
Normal Human
33%
Serum (Blood)
33%
Upregulation
16%
Titer
16%
Blood Clotting
16%
Homogenate
16%
Complement Activation
16%
C57BL 6 Mouse
16%
Cardiolipin Antibody
16%
Complement Component 5
16%
Complement Inhibition
16%
Neuroscience
In Vivo
100%
Phospholipid Antibody
100%
Complement Component C5
100%
Nomacopan
100%
Antiphospholipid Syndrome
83%
Thromboplastin
66%
Thrombus
66%
Coagulation System
16%
Cardiolipin Antibody
16%
Recombinant Protein
16%